Company news

KPC Pharmaceuticals, Inc. news in 2025

KPC Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Resolutions of the 12th Meeting of the 11th Board of Directors

December 30, 2025

Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025

December 29, 2025

Announcement on Progress in External Guarantees

December 22, 2025

Announcement on Resolutions of the 11th Meeting of the 11th Board of Directors

December 9, 2025

Announcement on Convening the Q3 2025 Performance Briefing

October 28, 2025

Announcement on Resolutions of the 9th Meeting of the 11th Board of Directors

October 24, 2025

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

October 10, 2025

Announcement on Using Idle Own Funds for Investment and Wealth Management Business

September 17, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

August 20, 2025

2025 Semi-annual Report

August 15, 2025

Announcement on Implementation of Dividend Distribution for 2024

July 21, 2025

Announcement on Progress in External Guarantee

June 24, 2025

Announcement on Resolution of the 6th Meeting of the 11th Board of Directors

June 23, 2025

Announcement on Resolution of the 2024 Annual General Meeting

June 20, 2025

Notice on Convening the 2024 Annual General Meeting

May 29, 2025

Announcement on Convening the Q1 2025 Performance Briefing

May 21, 2025

Announcement on Attending the 2024 Online Collective Reception Day for Investors of Listed Companies in Yunnan Jurisdiction

May 12, 2025

Announcement on Resolution of the 4th Meeting of the 11th Board of Directors

April 28, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

April 18, 2025

Announcement on Resignation of Senior Management Member

March 27, 2025

Indicative Announcement on Publication of 2024 Annual Performance Announcement by Indirect Controlling Shareholder China Resources Pharmaceutical Group Limited of Controlling Shareholder

March 26, 2025

Announcement on 2025 Guarantee Plan

March 25, 2025

Announcement on Resolution of the 2nd Meeting of the 11th Board of Directors

March 11, 2025

Announcement on Obtaining Drug Clinical Trial Approval Notification

February 28, 2025

Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025

February 13, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 10, 2025

Announcement on the Provision of Online Voting Reminder Service for the General Meeting

February 7, 2025

Announcement on Increasing Idle Self-owned Funds for Investment and Financial Business

January 22, 2025

Indicative Announcement on the Acceptance of New Drug Application

January 14, 2025

Announcement on Intended Selection in the National Traditional Chinese Medicine Joint Procurement Alliance's Centralized Procurement

January 2, 2025